Literature DB >> 15234431

Diagnostic assessment before Fontan operation in patients with bidirectional cavopulmonary anastomosis: are noninvasive methods sufficient?

Pamela S Ro1, Jack Rychik, Meryl S Cohen, William T Mahle, Jonathan J Rome.   

Abstract

OBJECTIVES: This study was designed to determine if a subset of patients who have undergone bidirectional cavopulmonary anastomosis could be identified in which catheterization was of little benefit before completion of the Fontan procedure.
BACKGROUND: Diagnostic evaluation before Fontan procedure has typically included cardiac catheterization. However, the overall management strategy for patients with functional single ventricle has evolved to include staging bidirectional cavopulmonary anastomosis in most, and it has become uncommon to exclude patients from Fontan based on catheterization data.
METHODS: Patients who underwent bidirectional cavopulmonary anastomosis and had complete echocardiograms and catheterizations within three months of each other between January 1992 and October 1997 were evaluated with a series of clinical and echocardiographic characteristics to identify a subset in whom catheterization was predicted to be of little added value ("no-cath" group). The predictive value and sensitivity of these criteria in excluding patients who required additional intervention, were excluded from Fontan, or died within 30 days of Fontan was determined.
RESULTS: A total of 99 patients who underwent bidirectional cavopulmonary anastomosis at 6.7 months (range 2.9 months to 14 years) were studied; 46 met criteria for the "no-cath" group. Noninvasive criteria stratified all patients who died (n = 5) or did not proceed to Fontan (n = 1) and 9 of 11 who required additional interventions to the "cath" group. Thus, the negative predictive value of these criteria was 93%.
CONCLUSIONS: Our data suggest that catheterization before Fontan could be avoided in a large percentage of patients without adversely affecting outcome; prospective evaluation of this strategy is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15234431     DOI: 10.1016/j.jacc.2004.02.058

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  The role of cardiovascular magnetic resonance in candidates for Fontan operation: proposal of a new algorithm.

Authors:  Lamia Ait-Ali; Daniele De Marchi; Massimo Lombardi; Luigi Scebba; Eugenio Picano; Bruno Murzi; Pierluigi Festa
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-11       Impact factor: 5.364

2.  What is the clinical utility of routine cardiac catheterization before a Fontan operation?

Authors:  Puja Banka; Doff B McElhinney; Emile A Bacha; John E Mayer; Kimberlee Gauvreau; Tal Geva; David W Brown
Journal:  Pediatr Cardiol       Date:  2010-05-26       Impact factor: 1.655

Review 3.  The role of MRI and CT in congenital heart disease.

Authors:  Rajesh Krishnamurthy
Journal:  Pediatr Radiol       Date:  2009-04

Review 4.  Is routine cardiac catheterization necessary in the management of patients with single ventricles across staged Fontan reconstruction? No!

Authors:  M A Fogel
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 6.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

7.  Routine Cardiac Catheterization Prior to Fontan Operation: Is It a Necessity?

Authors:  Bassel Mohammad Nijres; Joshua J Murphy; Karim Diab; Sawsan Awad; Ra-Id Abdulla
Journal:  Pediatr Cardiol       Date:  2018-02-03       Impact factor: 1.655

Review 8.  Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.

Authors:  Frances M Mitchell; Sanjay K Prasad; Gerald F Greil; Peter Drivas; Vassilios S Vassiliou; Claire E Raphael
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 9.  The role of cardiovascular magnetic resonance in pediatric congenital heart disease.

Authors:  Hopewell N Ntsinjana; Marina L Hughes; Andrew M Taylor
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-21       Impact factor: 5.364

Review 10.  State of the art of the Fontan strategy for treatment of univentricular heart disease.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Ad J C C Bogers; Willem A Helbing
Journal:  F1000Res       Date:  2018-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.